Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tekmira Pharma begins patient dosing in Phase 1 TKM-PLK1 trial
TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target. TKM-PLK1 has been shown in preclinical animal
TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target. TKM-PLK1 has been shown in preclinical animal
EpiPen is used for emergency treatment of severe allergic reactions (anaphylaxis). The distribution rights to EpiPen for Europe will be transferred to Meda from current distributors. As part
Antares Pharma said that the NDA filing was supported by a Phase 3 clinical trial, which demonstrated a reduction in urinary incontinence episodes for both doses studied (56mg
RegeneRx claims that RGN-259 is a sterile, preservative-free topical eye drop formulation of the novel therapeutic peptide Thymosin beta 4, or Tß4. The Phase 2 trial is expected
Under the agreement, Merck Sereno will co- market the product together with Bouchara Recordati, the group’s French subsidiary. Recordati and Merck claim that the drug has the potential
The randomised, double-blind, dose-response study is designed to assess the safety and efficacy of BCX4208 in combination with allopurinol in patients who have not reached the serum uric
The FDA approval of Gardasil applies for prevention of anal cancer caused by HPV types 16 and 18, and for the prevention of AIN caused by HPV types
Byetta (exenatide) is an injectable diabetes medicine that helps control blood sugar levels and it helps pancreas produce insulin more efficiently. Amylin Pharma and Eli Lilly said that
Delcath Systems is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver. Delcath
PODS, a Web-based ‘Lite’ EHRs system, gathers data in a common database with access controls to protect providers’ proprietary data, healthdatamanagement.com reported. Providers can import data into PODS